Skip to content

RICKYMONS: what changed

BE 1003.857.651NACE 86.940, Nursing and midwiferyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€34,778
2024 · €23,524+€11,254
Equity
€59,803
2024 · €25,024+€34,778
Cash
€0
2024 · -+€0
Balance sheet total
€70,704
2024 · €36,032+€34,673

Largest movements

2024 to 2025
Assets
  • Receivables after one year +€37,910

    up €37,910 (+126%), from €30,000 to €67,910

  • Deferred charges and accrued income -€3,605

    no longer reported in 2025 (was €3,605)

Equity and liabilities
  • Profit (loss) carried forward +€34,778

    up €34,778 (+148%), from €23,524 to €58,303

Income statement
  • Taxes -€8,163

    no longer reported in 2025 (was €8,163)

  • Gross operating margin +€1,716

    up €1,716 (+5.2%), from €33,072 to €34,788

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €23,524
Gross operating margin +€1,716
Other operating items +€1,272
Financial charges +€103
Taxes +€8,163
Result 2025 €34,778
raises the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€0
Investment €0
Financing €0
Cash 2024 €0
Net result for the year +€34,778
Receivables after one year -€37,910
Receivables within one year -€368
Deferred charges and accrued income +€3,605
Trade debts -€106
Cash 2025 €0
brings cash intakes cash out
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €36,032 €70,704 +€34,673 +96.2%
Current assets 29/58 €36,032 €70,704 +€34,673 +96.2%
Amounts receivable after more than one year 29 €30,000 €67,910 +€37,910 +126%
Other amounts receivable 291 €30,000 €67,910 +€37,910 +126%
Amounts receivable within one year 40/41 €2,427 €2,794 +€368 +15.1%
Other amounts receivable 41 €2,427 €2,794 +€368 +15.1%
Cash at bank and in hand 54/58 - €0 +€0
Deferred charges and accrued income 490/1 €3,605 - -€3,605
Total equity and liabilities 10/49 €36,032 €70,704 +€34,673 +96.2%
Equity 10/15 €25,024 €59,803 +€34,778 +139%
Contributions 10/11 €1,500 €1,500 = 0.0%
Profit (loss) carried forward 14 €23,524 €58,303 +€34,778 +148%
Amounts payable 17/49 €11,007 €10,902 -€106 -1.0%
Amounts payable within one year 42/48 €11,007 €10,902 -€106 -1.0%
Trade debts 44 €2,845 €2,739 -€106 -3.7%
Suppliers 440/4 €2,845 €2,739 -€106 -3.7%
Taxes, remuneration and social security 45 €8,163 €8,163 = 0.0%
Taxes 450/3 €8,163 €8,163 = 0.0%
Non-recurring operating charges 66A €1,272 - -€1,272
Gross operating margin 9900 €33,072 €34,788 +€1,716 +5.2%
Operating profit (loss) 9901 €31,800 €34,788 +€2,988 +9.4%
Financial charges 65/66B €113 €10 -€103 -91.2%
Recurring financial charges 65 €113 €10 -€103 -91.2%
Profit (loss) for the period before taxes 9903 €31,687 €34,778 +€3,091 +9.8%
Income taxes 67/77 €8,163 - -€8,163
Profit (loss) for the period 9904 €23,524 €34,778 +€11,254 +47.8%
Profit (loss) for the period to be appropriated 9905 €23,524 €34,778 +€11,254 +47.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€136,283 to €178,836

Midpoint €154,014 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €59,803
Capitalised earnings €212,764 to €297,870
Indication €136,283 to €178,836

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€59,803
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€59,803

Capitalised earnings

net result for the year (9904)
2025
€34,778
2024
€23,524
excluding non-recurring income and charges
€24,796
Average result, excluding non-recurring income and charges
€29,787
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€212,764 / €248,225 / €297,870

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.